Death Language for Code Status Discussions
(CODE-EMRS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different ways of discussing CPR (a procedure to restart the heart) affect patient decisions about whether to opt for it if their heart stops. Specifically, it examines whether using straightforward language about death, known as "Death Language," influences patients to decline CPR. Participants will fill out electronic surveys and have the opportunity to discuss their choices with doctors. The trial is suitable for individuals over 65 who can read and speak English and are not currently in intensive care. As an unphased trial, it offers participants the chance to contribute to important research that could enhance communication about critical healthcare decisions.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on communication and decision-making rather than medication use.
What prior data suggests that this method is safe for code status discussions?
A previous study showed that the way doctors discuss code status—whether to perform life-saving measures—can influence patient choices. Research suggests that when doctors use direct language about death, patients might be more likely to choose a "do not resuscitate" (DNR) order compared to when they use more neutral language. Although no direct evidence exists about the safety of using this kind of language, it's important to know that participating in these studies involves no physical risk. The focus is on communication and decision-making, where participants simply answer questions about their medical treatment preferences in case of a serious health issue. This means there are no safety concerns related to medical procedures or treatments.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how the language used in medical discussions about cardiopulmonary resuscitation (CPR) can influence patient decisions. The trial compares "death language," which directly mentions the possibility of death without resuscitation, to standard language that does not. By examining how these different approaches affect decision-making, researchers hope to gain insights into improving communication between healthcare providers and patients, potentially leading to more informed and personalized care choices.
What evidence suggests that this trial's methods could be effective for improving code status discussions?
Research has shown that the words healthcare providers use can influence decisions about do-not-resuscitate (DNR) orders. In this trial, participants will encounter different language styles to assess their impact on decision-making. One group will hear straightforward language about death, which earlier studies found makes patients more likely to choose DNR. This approach helps patients better understand the situation, including the fact that CPR (cardiopulmonary resuscitation) succeeds only about 1 in 7 times. Patients often make better decisions when they know the possible outcomes, such as brain and organ damage, even if the heart restarts. Clear communication is essential to help patients make choices that align with their values and wishes.16789
Who Is on the Research Team?
Karthik J Kota, MD MPH
Principal Investigator
Assistant Professor of Medicine
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals over the age of 65 who can consent to participate. It aims to improve how code status preferences are communicated and documented in medical records, focusing on patients' choices regarding resuscitation efforts.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Survey Completion
Participants fill out study questionnaires electronically and have options to speak to a study physician for clarification
Follow-up
Participants receive weekly reminders to complete the study and have the option to withdraw
What Are the Treatments Tested in This Trial?
Interventions
- Death Language
Trial Overview
The study tests different ways of asking patients about their resuscitation preferences using 'death language' in electronic medical records. It examines if certain phrasings influence decisions and how doctors agree with these choices based on objective data.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will be asked: The purpose of this trial is to understand how the words we use to describe CPR affect patient decisions. Cardiopulmonary resuscitation (CPR) is performed when the heart stops beating. It consists of electric shocks to the heart, pumping the chest to circulate blood, and using a breathing machine to help with breathing. The success rate of CPR is about 1 in 7, and even when the heart restarts, the brain and other organs can be damaged. If your heart were to stop beating and you were to die without resuscitation, would you prefer that we attempt cardiopulmonary resuscitation (CPR), or would you prefer that we do not resuscitate (DNR)?
Participants will be asked: The purpose of this trial is to understand how the words we use to describe CPR affect patient decisions. Cardiopulmonary resuscitation (CPR) is performed when the heart stops beating. It consists of electric shocks to the heart, pumping the chest to circulate blood, and using a breathing machine to help with breathing. The success rate of CPR is about 1 in 7, and even when the heart restarts, the brain and other organs can be damaged. If your heart were to stop beating, would you prefer that we attempt cardiopulmonary resuscitation (CPR), or would you prefer that we do not resuscitate (DNR)?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
Citations
Checklist-Guided Code Status Discussions in Patients ... - PMC
The primary outcome was the documented code status in the electronic patient record on the day of code status discussions (rate of do-not- ...
Differences in code status and end of life decision making in ...
The purpose of this study was to determine if code status, advance directives, decisions to limit life support were different for ICU patients with LEP
Individualized decision making in on-scene resuscitation ...
We developed and validated reinforcement learning models for individualized on-scene resuscitation times, leveraging nationwide Korean data.
Do not attempt cardiopulmonary resuscitation decision ...
Code status discussions in medical Inpatients: results of a survey of patients and physicians. Swiss Med Wkly 2020;150:w20194. doi:10.4414/smw.2020.20194.
Communication Strategies in a Code Status Conversation - PMC
Because code status decisions involve potentially limiting a life-prolonging intervention, clinicians should engage in a shared decision-making process (1).
Language for Routine Code Status Discussions
Discussing code status can be challenging during an initial encounter with a patient because clinicians often do not have enough time or ...
Quantifying the Association Between Code Status ...
Patients with a DNR order faced much higher mortality compared with those who were full code (46.9% vs. 25.3%) (Table 1). In the primary analysis, we observed a ...
8.
thebottomline.org.uk
thebottomline.org.uk/summaries/icm/shared-decision-making-in-resuscitation-decisions/Shared Decision Making in Resuscitation Decisions
In hospitalized adults requiring code status discussions, does a shared decision-making approach (including a checklist and decision aid) ...
Code status orders in patients admitted to the intensive ...
Among 147 patients who died during hospitalization, 95.2% (140) died with DNR code status; most (86.4%) died within two days of final code status change.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.